Teva Pharmaceuticals Surges to 424th in Trading Volume with $228 Million Turnover Despite Stock Decline

On June 13, 2025, Teva Pharmaceuticals (TEVA) saw a significant increase in trading volume, with a total turnover of $228 million, marking a 55.12% rise from the previous day. This surge placed Teva at the 424th position in terms of trading volume for the day. However, despite the high trading volume, Teva's stock price declined by 4.07%.

Teva Pharmaceuticals (TEVA) experienced a notable increase in put option trading, with 6,307 puts traded, which is 1.8 times the expected volume. The most active options were the Jun-25 17.5 puts and Jun-25 17 calls, with a total volume of nearly 5,800 contracts. The Put/Call Ratio stood at 2.47, and the at-the-money implied volatility (IV) rose by over 2 points during the day. Earnings for Teva are anticipated to be released on July 30th.

JPMorgan analysts have expressed a positive outlook on Teva, stating that the company is well-positioned for potential upside from its current position. This sentiment from a major financial institution could influence investor confidence and potentially impact Teva's stock performance in the coming days.